PL367940A1 - Analogi przeciwnowotworowe - Google Patents

Analogi przeciwnowotworowe

Info

Publication number: PL367940A1
Authority: PL; Poland
Prior art keywords: antitumoral; analogs; antitumoral analogs; ecteinascidin; derivatives
Prior art date: 2001-08-07

Application number

PL02367940A

Other languages

English (en)

Other versions

PL218295B1 (pl

Inventor

Valentin Martinez

Pilar Gallego

Carmen Cuevas

Simon Munt

Ignacio Manzanares

Original Assignee

Pharma Mar, S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-07

Filing date

2002-08-06

Publication date

2005-03-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9919954&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL367940(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-08-06 Application filed by Pharma Mar, S.A. filed Critical Pharma Mar, S.A.

2005-03-07 Publication of PL367940A1 publication Critical patent/PL367940A1/pl

2014-11-28 Publication of PL218295B1 publication Critical patent/PL218295B1/pl

Links

230000000259 anti-tumor effect Effects 0.000 title 1
PKVRCIRHQMSYJX-AIFWHQITSA-N trabectedin Chemical class C([C@@]1(C(OC2)=O)NCCC3=C1C=C(C(=C3)O)OC)S[C@@H]1C3=C(OC(C)=O)C(C)=C4OCOC4=C3[C@H]2N2[C@@H](O)[C@H](CC=3C4=C(O)C(OC)=C(C)C=3)N(C)[C@H]4[C@@H]21 PKVRCIRHQMSYJX-AIFWHQITSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Saccharide Compounds (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Compounds Of Unknown Constitution (AREA)

PL367940A 2001-08-07 2002-08-06 Pochodne ekteinascydyny, kompozycja je zawierająca oraz ich zastosowanie PL218295B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0119243.4A GB0119243D0 (en)	2001-08-07	2001-08-07	Antitumoral analogs of ET-743
PCT/GB2002/003592 WO2003014127A1 (en)	2001-08-07	2002-08-06	Antitumoral analogs

Publications (2)

Publication Number	Publication Date
PL367940A1 true PL367940A1 (pl)	2005-03-07
PL218295B1 PL218295B1 (pl)	2014-11-28

Family

ID=9919954

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL367940A PL218295B1 (pl)	2001-08-07	2002-08-06	Pochodne ekteinascydyny, kompozycja je zawierająca oraz ich zastosowanie

Country Status (22)

Country	Link
US (1)	US7763615B2 (pl)
EP (3)	EP2270018A1 (pl)
JP (2)	JP4684552B2 (pl)
KR (1)	KR20040032150A (pl)
CN (1)	CN100334094C (pl)
AT (1)	ATE374777T1 (pl)
AU (1)	AU2002313540B2 (pl)
CA (1)	CA2455768C (pl)
CY (1)	CY1107830T1 (pl)
DE (1)	DE60222775T2 (pl)
DK (1)	DK1414828T3 (pl)
ES (1)	ES2294151T3 (pl)
GB (1)	GB0119243D0 (pl)
HU (1)	HU229779B1 (pl)
IL (2)	IL160051A0 (pl)
MX (1)	MXPA04001240A (pl)
NO (1)	NO337476B1 (pl)
NZ (1)	NZ530837A (pl)
PL (1)	PL218295B1 (pl)
PT (1)	PT1414828E (pl)
RU (1)	RU2283842C2 (pl)
WO (1)	WO2003014127A1 (pl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0202544D0 (en) *	2002-02-04	2002-03-20	Pharma Mar Sa	The synthesis of naturally occuring ecteinascidins and related compounds
CA2727055C (en)	2008-01-11	2016-12-20	Albany Molecular Research, Inc.	(1-azinone) -substituted pyridoindoles as mch antagonists
WO2011003005A1 (en) *	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
US8629158B2 (en) *	2009-07-01	2014-01-14	Albany Molecular Research, Inc.	Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
WO2011003021A1 (en) *	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
WO2011003012A1 (en) *	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
WO2011147828A1 (en)	2010-05-25	2011-12-01	Pharma Mar, S.A.	Synthetic process for the manufacture of ecteinascidin compounds
EP2786755A3 (en) *	2010-11-12	2014-10-29	Pharma Mar S.A.	Combination therapy with an antitumor alkaloid
RU2606306C2 (ru)	2010-11-26	2017-01-10	Нек Корпорейшн	Устройство видеокодирования, устройство видеодекодирования, способ видеокодирования, способ видеодекодирования и программа
US8697700B2 (en)	2010-12-21	2014-04-15	Albany Molecular Research, Inc.	Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof
WO2012088124A2 (en)	2010-12-21	2012-06-28	Albany Molecular Research, Inc.	Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
CN108271369A (zh)	2015-10-23	2018-07-10	法尔玛赞公司	用于制备色胺及其衍生物的新工艺
LT3615544T (lt) *	2017-04-27	2023-05-10	Pharma Mar S.A.	Priešnavikiniai junginiai
TWI824043B (zh) *	2018-10-25	2023-12-01	西班牙商瑪製藥股份有限公司	藥物抗體共軛物
TW202116783A (zh)	2019-09-03	2021-05-01	西班牙商瑪製藥股份有限公司	盧比克替定治療惡性間皮瘤
CN112574234B (zh) *	2019-09-27	2022-05-24	江苏恒瑞医药股份有限公司	一种海鞘素衍生物的制备方法
MA56827B2 (fr)	2019-11-21	2023-09-27	Pharma Mar Sa	Procédés de traitement du cancer du poumon à petites cellules avec des formulations de lurbinectédine
WO2021228414A1 (en)	2020-05-14	2021-11-18	Pharma Mar, S.A.	Methods of treating small cell lung cancer with lurbinectedin formulations
CA3158733A1 (en) *	2019-11-21	2021-05-27	Pilar Calvo	Methods of treating small cell lung cancer with lurbinectedin formulations
CR20220581A (es)	2020-04-21	2023-01-09	Pharma Mar Sa	Conjugados de anticuerpos de fármacos
WO2021218896A1 (zh) *	2020-04-26	2021-11-04	江苏恒瑞医药股份有限公司	海鞘素类衍生物及其制备方法与医药用途
AU2020466790B2 (en)	2020-09-04	2025-07-10	Pharma Mar, S.A.	Combination of lurbinectedin and immune checkpoint inhibitor
WO2022101255A1 (en)	2020-11-10	2022-05-19	Pharma Mar, S.A.	Lurbinectedin and irinotecan combinations
IN202141039393A (pl) *	2021-08-31	2023-03-03
CA3237009A1 (en)	2021-11-08	2023-05-11	Luis Gonzaga PAZ-ARES RODRIGUEZ	Lurbinectedin and atezolizumab combinations
CN115246846B (zh) *	2021-11-19	2024-10-01	江苏慧聚药业股份有限公司	卢比替定新晶型及其制备
CN118388507A (zh)	2022-04-08	2024-07-26	上海皓元医药股份有限公司	一种卢比替定的晶型及其制备方法
CN114940682A (zh) *	2022-05-18	2022-08-26	博瑞制药(苏州)有限公司	芦比替定的晶型及其制备方法和用途
WO2024186263A1 (en) *	2023-03-07	2024-09-12	Axcynsis Therapeutics Pte. Ltd.	Antibody-drug conjugates comprising trabectedin and lurbinectedin derivatives
WO2024188978A1 (en)	2023-03-10	2024-09-19	Pharma Mar, S.A.	Lurbinectedin as mcl-1 inhibitor and combinations thereof for use in treating cancer
WO2025059336A1 (en) *	2023-09-13	2025-03-20	Navinta, Llc	An improved process for preparation of lurbinectedin
CN121986103A (zh)	2023-10-09	2026-05-05	法马马有限公司	用于制造海鞘素化合物的合成方法
EP4563149A1 (en)	2023-11-30	2025-06-04	Pharma Mar, S.A.	Lurbinectedin, ecubectedin and a related compound for use in the treatment of skin cancers
WO2025168075A1 (zh) *	2024-02-08	2025-08-14	映恩生物科技(上海)有限公司	海鞘素类化合物及其应用
TW202610629A (zh)	2024-07-26	2026-03-16	西班牙商瑪製藥股份有限公司	用於製造海鞘素化合物的合成方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59225189A (ja)	1983-06-03	1984-12-18	Shionogi & Co Ltd	キノナミン誘導体およびその製造法
JPS6084288A (ja)	1983-10-13	1985-05-13	Shionogi & Co Ltd	シアノキノナミンアセテ−ト類およびその製造法
EP0309477B1 (en)	1986-06-09	1991-11-06	The Board Of Trustees Of The University Of Illinois	Ecteinascidins 729, 743, 745, 759a, 759b and 770
US5089273A (en)	1986-06-09	1992-02-18	Board Of Trustees Of The University Of Illinois	Ecteinascidins 729, 743, 745, 759A, 759B and 770
US5256663A (en)	1986-06-09	1993-10-26	The Board Of Trustees Of The University Of Illinois	Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
US5149804A (en) *	1990-11-30	1992-09-22	The Board Of Trustees Of The University Of Illinois	Ecteinascidins 736 and 722
US5478932A (en) *	1993-12-02	1995-12-26	The Board Of Trustees Of The University Of Illinois	Ecteinascidins
US5721362A (en)	1996-09-18	1998-02-24	President And Fellows Of Harvard College	Process for producing ecteinascidin compounds
US5985876A (en)	1997-04-15	1999-11-16	Univ Illinois	Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
BR9909488B1 (pt) *	1998-04-06	2011-02-08		ecteinascidinas semi-sintéticas e composição farmacêutica.
IL139607A0 (en)	1998-05-11	2002-02-10	Pharma Mar Sa	Metabolites of ecteinascidin 743
US6124292A (en) *	1998-09-30	2000-09-26	President And Fellows Of Harvard College	Synthetic analogs of ecteinascidin-743
MY130271A (en)	1999-05-14	2007-06-29	Pharma Mar Sa	Hemisynthetic method and new compounds
EP1254140A4 (en) *	2000-01-19	2003-03-12	Univ Columbia	SAFRAMYCIN-ECTEINASCIDIN SERIES COMPOUNDS, USAGE AND SYNTHESIS THEREOF
KR100886496B1 (ko)	2000-04-12	2009-03-05	파르마 마르, 에스.에이.	항종양성 엑티나시딘 유도체
MXPA02011319A (es) *	2000-05-15	2003-06-06	Pharma Mar Sa	Analogos antitumorales de ecteinascidina 743.

2001
- 2001-08-07 GB GBGB0119243.4A patent/GB0119243D0/en not_active Ceased
2002
- 2002-08-06 RU RU2004106617/04A patent/RU2283842C2/ru active
- 2002-08-06 EP EP10180740A patent/EP2270018A1/en not_active Withdrawn
- 2002-08-06 CN CNB028196511A patent/CN100334094C/zh not_active Expired - Lifetime
- 2002-08-06 DK DK02753134T patent/DK1414828T3/da active
- 2002-08-06 PT PT02753134T patent/PT1414828E/pt unknown
- 2002-08-06 MX MXPA04001240A patent/MXPA04001240A/es active IP Right Grant
- 2002-08-06 PL PL367940A patent/PL218295B1/pl unknown
- 2002-08-06 DE DE60222775T patent/DE60222775T2/de not_active Expired - Lifetime
- 2002-08-06 EP EP02753134A patent/EP1414828B9/en not_active Expired - Lifetime
- 2002-08-06 AT AT02753134T patent/ATE374777T1/de active
- 2002-08-06 HU HU0401174A patent/HU229779B1/hu unknown
- 2002-08-06 ES ES02753134T patent/ES2294151T3/es not_active Expired - Lifetime
- 2002-08-06 WO PCT/GB2002/003592 patent/WO2003014127A1/en not_active Ceased
- 2002-08-06 JP JP2003519076A patent/JP4684552B2/ja not_active Expired - Lifetime
- 2002-08-06 IL IL16005102A patent/IL160051A0/xx unknown
- 2002-08-06 EP EP07001308A patent/EP1806349A1/en not_active Ceased
- 2002-08-06 NZ NZ530837A patent/NZ530837A/en not_active IP Right Cessation
- 2002-08-06 CA CA2455768A patent/CA2455768C/en not_active Expired - Lifetime
- 2002-08-06 US US10/485,536 patent/US7763615B2/en active Active
- 2002-08-06 AU AU2002313540A patent/AU2002313540B2/en active Active
- 2002-08-06 KR KR10-2004-7001924A patent/KR20040032150A/ko not_active Ceased
2004
- 2004-01-26 IL IL160051A patent/IL160051A/en active IP Right Grant
- 2004-03-05 NO NO20040961A patent/NO337476B1/no not_active IP Right Cessation
2007
- 2007-12-12 CY CY20071101576T patent/CY1107830T1/el unknown
2010
- 2010-09-17 JP JP2010209928A patent/JP2011026331A/ja active Pending

Also Published As

Publication number	Publication date
RU2004106617A (ru)	2005-04-10
WO2003014127A1 (en)	2003-02-20
NO20040961L (no)	2004-03-05
EP1414828A1 (en)	2004-05-06
HK1065786A1 (en)	2005-03-04
NZ530837A (en)	2005-07-29
EP1414828B9 (en)	2008-02-20
JP2011026331A (ja)	2011-02-10
IL160051A (en)	2012-01-31
GB0119243D0 (en)	2001-10-03
JP4684552B2 (ja)	2011-05-18
EP2270018A1 (en)	2011-01-05
DE60222775D1 (de)	2007-11-15
IL160051A0 (en)	2004-06-20
ES2294151T3 (es)	2008-04-01
PL218295B1 (pl)	2014-11-28
CA2455768C (en)	2011-10-11
EP1806349A1 (en)	2007-07-11
US20060128711A1 (en)	2006-06-15
MXPA04001240A (es)	2004-06-03
DK1414828T3 (da)	2008-02-04
ATE374777T1 (de)	2007-10-15
DE60222775T2 (de)	2008-07-17
US7763615B2 (en)	2010-07-27
HUP0401174A3 (en)	2005-12-28
RU2283842C2 (ru)	2006-09-20
NO337476B1 (no)	2016-04-18
CA2455768A1 (en)	2003-02-20
EP1414828B1 (en)	2007-10-03
CN100334094C (zh)	2007-08-29
HUP0401174A2 (hu)	2005-09-28
JP2005501093A (ja)	2005-01-13
CY1107830T1 (el)	2013-06-19
CN1564822A (zh)	2005-01-12
HU229779B1 (en)	2014-07-28
PT1414828E (pt)	2007-12-27
KR20040032150A (ko)	2004-04-14
AU2002313540B2 (en)	2008-05-22

Publication	Publication Date	Title
GB0119243D0 (en)	2001-10-03	Antitumoral analogs of ET-743
TW263423B (pl)	1995-11-21
SV2003001076A (es)	2003-07-29	Compuestos y procedimientos antitumorales ref. x-14776
JO2410B1 (en)	2007-06-17	6. Replaced pyrido-pyrimidines
EP0562049A4 (en)	1994-09-28	Novel 4-arylpiperazines and 4-arylpiperidines
MY120090A (en)	2005-08-30	Chemical compounds.
PL304649A1 (en)	1995-02-20	Novel derivatives of taxane and pharmaceutical agents
SI1280809T1 (sl)	2005-12-31	Antitumorski ekteinascidin derivati
HUP0400648A3 (en)	2012-09-28	Compositions for antitumour treatment containing ecteinascidin 743
EP1383490A4 (en)	2009-03-18	COMBINATION OF EPOTHILON ANALOGUES AND CHEMOTHERAPEUTICS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
IL159418A0 (en)	2004-06-01	Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
IL160437A0 (en)	2004-07-25	INDENO [1,2-c] ISOQUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IL139960A0 (en)	2002-02-10	Macrocylic analogs and methods of their use and preparation
MXPA04003886A (es)	2004-07-08	Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
PL371464A1 (pl)	2005-06-13	3-Alkilowane 5,5',6,6',7,7',8,8'-oktahydro-2,2'-binaftole i 3,3'-dialkilowane 5,5',6,6',7,7',8,8'-oktahydro-2,2'-binaftole oraz sposoby ich wytwarzania
EP1385514A4 (en)	2005-04-13	SPIROINDEN AND SPIROINDAN COMPOUNDS
GB9923077D0 (en)	1999-12-01	Sapogenin derivatives and their use
SI0683979T1 (en)	1999-10-31	Suspension concentrate compositions of arylpyrrole insecticidal and acaricidal agents
GB0218816D0 (en)	2002-09-18	Antitumoral analogs of lamellarins
EP1664093B8 (en)	2008-08-13	Antitumoral compounds based on Kahalalide F
GB9921578D0 (en)	1999-11-17	Omeprazole synthesis
EP1469000A4 (en)	2005-12-07	NEW CRYSTALLINE TRICYCLIC TRIAZOLOBENZAZEPINE DERIVATIVE
YU83903A (sh)	2006-08-17	Farmaceutske kombinacije zasnovane na derivatima piridoindolona
DE60237360D1 (en)	2010-09-30	Glycopeptidantibiotika
SI1365808T1 (sl)	2011-06-30	Sestavki za protitumorsko zdravljenje vsebujoäśi esteinascidin 743